Omos Bio Making pre-cancer treatable
1 known investors
Omos Biosciences develops molecular diagnostic tools that analyze the molecular signatures of pre-cancers to identify which cases are high risk and require intervention. The technology is aimed at helping clinicians with treatment stratification to reduce over-treatment and enable early cancer intervention.
Investors · 1
Frequently asked questions
- What does Omos Bio Making pre-cancer treatable do?
- Omos Biosciences develops molecular diagnostic tools that analyze the molecular signatures of pre-cancers to identify which cases are high risk and require intervention. The technology is aimed at helping clinicians with treatment stratification to reduce over-treatment and enable early cancer intervention.
- Who are Omos Bio Making pre-cancer treatable's investors?
- Omos Bio Making pre-cancer treatable's investors include Spacecadet Ventures.